 |
 |
Dear Listfriends, I thought this news item might be of interest: ================================== New Antiparkinsonism Agents About To Enter Trials BARCELONA, SPAIN, Apr 07 (Reuters) - The first of several innovative neuroprotective drugs will soon be ready for clinical testing, Professor Warren Olanow of Mount Sinai School of Medicine in New York told 'Uniting for Tomorrow,' an international conference on Parkinson's disease here. The goal of neuroprotection is to prevent the degeneration of nerve cells in the substantia nigra pars compacta, which is a hallmark of Parkinson's disease. Current treatments are primarily directed at correcting the symptomatic consequences of the loss of these nerve cells. http://ipn.intelihealth.com/ipn/ihtIPN?c=178411 _ -- Kathrynne Holden, MS, RD "Nutrition you can live with!" Medical nutrition therapy http://www.nutritionucanlivewith.com/ Tel: 970-493-6532 // Fax: 970-493-6538